Glioblastoma: Overcoming fundamental biological and delivery barriers to therapy
Science Translational Medicine · 29.07.2026 · 18 (860)
DOI: 10.1126/scitranslmed.aeg8772 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Translational Medicine, erschienen am 29.07.2026. Verfasst von Genaro R Villa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Mass General Brigham, Boston, MA, USA. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
Glioblastoma remains the most aggressive primary malignant brain tumor in adults, with survival largely unchanged despite advances in molecular diagnostics and supportive care. Therapeutic failure reflects fundamental biological and anatomical barriers, including intratumoral heterogeneity, an immunosuppressive tumor microenvironment, and restricted drug delivery across the blood-brain barrier. In this Review, we summarize the current standard of care and critically examine emerging strategies aimed at overcoming these constraints, including locoregional delivery technologies, immunotherapy, biomarker-defined precision approaches, and adaptive clinical trial designs. We highlight key translational and clinical studies shaping the field and discuss principles for developing more effective, integrated therapeutic paradigms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Harvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Mass General Brigham, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Center for Tumors of the Nervous System, Mass General Brigham Cancer Institute, Boston, MA, USA.
- Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
- Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.
ORCID-Profile: Genaro R Villa, Ashish D Patel, David A Reardon, E Antonio Chiocca
Förderung
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Villa, G. R., Patel, A. D., Reardon, D. A., & Chiocca, E. A. (2026). Glioblastoma: Overcoming fundamental biological and delivery barriers to therapy. Science Translational Medicine, 18(860). https://doi.org/10.1126/scitranslmed.aeg8772
Vancouver
Villa GR, Patel AD, Reardon DA, Chiocca EA. Glioblastoma: Overcoming fundamental biological and delivery barriers to therapy. Science Translational Medicine. 2026;18(860). doi:10.1126/scitranslmed.aeg8772
BibTeX
@article{Villa2026,
author = {Villa, Genaro R and Patel, Ashish D and Reardon, David A and Chiocca, E Antonio},
title = {Glioblastoma: Overcoming fundamental biological and delivery barriers to therapy},
journal = {Science Translational Medicine},
year = {2026},
volume = {18},
number = {860},
doi = {10.1126/scitranslmed.aeg8772}
}
EUVIMED